Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Non-Current Liabilities (2018 - 2020)

Nephros (NEPH) has 9 years of Other Non-Current Liabilities data on record, last reported at $8.2 million in Q4 2020.

  • For Q4 2020, Other Non-Current Liabilities rose 2649.67% year-over-year to $8.2 million; the TTM value through Dec 2020 reached $8.2 million, up 2649.67%, while the annual FY2020 figure was $8.2 million, 2649.67% up from the prior year.
  • Other Non-Current Liabilities reached $8.2 million in Q4 2020 per NEPH's latest filing, up from $6000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $8.2 million in Q4 2020 and bottomed at $6000.0 in Q3 2020.
  • Average Other Non-Current Liabilities over 3 years is $1.3 million, with a median of $231000.0 recorded in 2019.
  • The widest YoY moves for Other Non-Current Liabilities: up 2649.67% in 2020, down 92.31% in 2020.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $263000.0 in 2018, then grew by 14.07% to $300000.0 in 2019, then surged by 2649.67% to $8.2 million in 2020.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $8.2 million in Q4 2020, $6000.0 in Q3 2020, and $300000.0 in Q4 2019.